News
Liver cancer could hit you sooner than you think. In an interview with HT Lifestyle, Dr Amar Mukund, Professor and Head of ...
1d
News Medical on MSNSerum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.
During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...
2d
Clinical Trials Arena on MSNCytovation secures $6m for trial of CY-101 to treat adrenocortical carcinomaThe trial will be a collaborative effort between the company, the Norwegian Cancer Society, and Cancer Research UK.
The fig summarizes the main treatment strategies for HCC. Hepatocellular carcinoma (HCC) is the most prevalent form of liver ...
Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...
Liver cancer, particularly Hepatocellular Carcinoma (HCC), is fast emerging as one of India’s most pressing health challenges ...
As India marks World Liver Day, health experts are raising concerns over the rising burden of liver cancer, a disease often ...
Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab ...
EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.
Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver disease, according to findings in JAMA Internal Medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results